GFAP and Parkinson disease: The findings were modest, revealing a small but significant increase in CSF GFAP in patients with PD and hyposmia compared to patients with PD and normal olfactory function (12.25 ± 3.87 vs 10.46 ± 3.68, p = 0.001).